Data Supports Further Investigation of Mesothelioma Virotherapy
Oncolytics Biotech presented data that indicates malignant mesothelioma cells are sensitive to certain viruses. Their presentation titled “Combination Immunotherapy and Oncolytics Virotherapy for the Treatment of Malignant Mesothelioma” discussed in vitro data showing mesothelioma cells could be suitable targets for reoviruses which could then attack and compromise them. The company currently has 7 ongoing phase […]
Data Supports Further Investigation of Mesothelioma Virotherapy Read More »